Abstract
Drug therapy for human immunodeficiency virus (HIV) is highly effective in suppressing viral replication and restoring immune function in patients with HIV. However, this same treatment can also be associated with immunotoxicity. For example, zidovudine and various other antiretroviral agents are capable of causing bone marrow suppression. Agents used to treat opportunistic infections in these individuals, including ganciclovir, foscarnet, and sulfamethoxazoletrimethoprim, can cause additional hematotoxicity. Drug-drug interactions must also be considered and managed in order to control iatrogenic causes of immunotoxicity. In this review, we examine the normal immune response to HIV, and the benefits of antiretroviral therapy in prolonging immune function. We then discuss immune-related adverse effects of drugs used to treat HIV and the opportunistic infections that are common among these patients. Finally, we address in vitro, animal, and clinical evidence of toxicity associated with various combination use of these agents.
Keywords: Human immunodeficiency virus, acquired immunodeficiency syndrome, antiretrovirals, adverse drug reactions, drug interactions, bone marrow toxicity, zidovudine
Current Pharmaceutical Design
Title: Effects of Antiretroviral Therapy on Immunity in Patients Infected with HIV
Volume: 12 Issue: 9
Author(s): B. A. Garvy, D. J. Feola and A. C. Thornton
Affiliation:
Keywords: Human immunodeficiency virus, acquired immunodeficiency syndrome, antiretrovirals, adverse drug reactions, drug interactions, bone marrow toxicity, zidovudine
Abstract: Drug therapy for human immunodeficiency virus (HIV) is highly effective in suppressing viral replication and restoring immune function in patients with HIV. However, this same treatment can also be associated with immunotoxicity. For example, zidovudine and various other antiretroviral agents are capable of causing bone marrow suppression. Agents used to treat opportunistic infections in these individuals, including ganciclovir, foscarnet, and sulfamethoxazoletrimethoprim, can cause additional hematotoxicity. Drug-drug interactions must also be considered and managed in order to control iatrogenic causes of immunotoxicity. In this review, we examine the normal immune response to HIV, and the benefits of antiretroviral therapy in prolonging immune function. We then discuss immune-related adverse effects of drugs used to treat HIV and the opportunistic infections that are common among these patients. Finally, we address in vitro, animal, and clinical evidence of toxicity associated with various combination use of these agents.
Export Options
About this article
Cite this article as:
Garvy A. B., Feola J. D. and Thornton C. A., Effects of Antiretroviral Therapy on Immunity in Patients Infected with HIV, Current Pharmaceutical Design 2006; 12 (9) . https://dx.doi.org/10.2174/138161206776055886
DOI https://dx.doi.org/10.2174/138161206776055886 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity
Mini-Reviews in Medicinal Chemistry Cationic Lipophilic Radiotracers for Functional Imaging of Multidrug Resistance
Current Radiopharmaceuticals Clinical Application of Lentiviral Vectors – Concepts and Practice
Current Gene Therapy Strategies for In Vivo siRNA Delivery in Cancer
Mini-Reviews in Medicinal Chemistry Applications of Muscle Electroporation Gene Therapy
Current Gene Therapy Therapeutic Targets for Metastatic Prostate Cancer
Current Drug Targets Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer
Current Medicinal Chemistry Thalidomide Analogues as Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Curcumin: Powerful Immunomodulator from Turmeric
Current Immunology Reviews (Discontinued) The Retinoblastoma Protein in Osteoblast Differentiation and Osteosarcoma
Current Molecular Medicine Discovery of 4-Aryl-4H-Chromenes as Potent Apoptosis Inducers Using a Cell- and Caspase-Based Anti-Cancer Screening Apoptosis Program (ASAP): SAR Studies and the Identification of Novel Vascular Disrupting Agents
Anti-Cancer Agents in Medicinal Chemistry Inhibition of HIV-1 Replication by RNA-Based Strategies
Current HIV Research Novel Adjunctive Therapies for the Treatment of Tuberculosis
Current Molecular Medicine PI3K-Akt Signaling and Viral Infection
Recent Patents on Biotechnology YB-1 Activities in Oncogenesis: Transcription and Translation
Current Cancer Therapy Reviews Targeting the Hippo Pathway for Anti-cancer Therapies
Current Medicinal Chemistry Nano Approaches to Enhance Pharmacokinetic and Pharmacodynamic Activity of Plant Origin Drugs
Current Nanoscience Cryopreservation of Ovarian Tissue: State of the Art in 2007
Current Women`s Health Reviews The use of Azoles Containing Natural Products in Cancer Prevention and Treatment: An Overview
Anti-Cancer Agents in Medicinal Chemistry Roles of Laminin-332 and α6β4 Integrin in Tumor Progression
Mini-Reviews in Medicinal Chemistry